Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Brain-Cleaning catheter could speed recovery after stroke

NCT ID NCT05970549

First seen Jan 27, 2026 · Last updated Jun 22, 2026 · Updated 18 times

Summary

This study is testing a special catheter called IRRAflow that both drains fluid and actively irrigates the brain to remove blood after a hemorrhage. The trial will compare this device to standard catheters in 17 adults with intraventricular hemorrhage. Researchers want to see if it reduces leftover blood and improves hospital outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAVENTRICULAR HEMORRHAGE (IVH) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10128, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

IRRAflow® Active Fluid Exchange System (a special catheter that irrigates and drains fluid from the brain)

What this could lead to

If it works, this could offer a safer and more effective way to remove blood from the brain after a hemorrhage, potentially leading to better recovery and shorter hospital stays.

What could go wrong

This is a very small early-stage study with only 17 participants, so results may not apply to everyone. The device is already FDA-approved, but its advantage over standard catheters is unproven, and there are always risks with brain procedures like infection or bleeding.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.